Different β‐adrenoceptor‐effector coupling in human ventricular and atrial myocardium

Abstract

To examine whether the downregulation of β‐adrenoceptors is accompanied by reduced β‐adrenoceptor‐mediated effects in atrial as well as in ventricular myocardium, we investigated the β‐adrenoceptor‐effector coupling in atrial and papillary muscle strips from patients with terminal heart failure (heart transplantation because of dilated cardiomyopathy; New York Heart Association Class IV, NYHA IV) and moderate heart failure (mitral valve replacement, NYHA II‐III) and in tissue from non‐failing hearts. The isometric force of contraction induced by isoprenaline (0·001‐1 μmoll^‐1) or Ca²⁺ 1·8–15 mmoll^‐1) in atrial muscle strips and papillary muscle strips has been measured. We also examined the number of β‐adrenoceptors in both tissues by radioligand binding.The degree of heart failure affected neither the potency (EC₅₀: control: 0·01 (0·001‐0·082) μmoll^‐1; NYHA II‐III: 0·01 (0·001‐0·125) μmoll^‐1; NYHA IV: 0·01 (0·001‐0·160) μmoll^‐1) nor the efficacy (NYHA IV: 7·8 ± 1·0 mN; NYHA II‐III: 6·1 ± 0·7 mN; control: 7·7 ± 0·9 mN) of the isoprenaline‐mediated increase in force of contraction in atrial muscle strips. This is in spite of a reduced number of β‐adrenoceptors in moderately (NYHA II‐III) and terminally (NYHA IV) failing atrial myocardium compared to non‐failing atrial myocardium (PPas well as by a progressive decrease of β‐adrenoceptors (PP2+ ‐mediated maximal increase in force of contraction in atrial and papillary muscle strips was similar in non‐failing and failing myocardial tissue.In conclusion, a surplus of β‐adrenoceptors for mediating positive inotropic effects seems to exist only in atrial but not in left ventricular human myocardium. Therefore, the efficacy of the β‐adrenoceptor‐effector coupling, at least in terms of positive inotropic effects, cannot be inferred for any tissue in the human myocardium.